Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics
Condition(s):Healthy; Type 2 Diabetes MellitusLast Updated:October 12, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Healthy; Type 2 Diabetes MellitusLast Updated:October 12, 2017Terminated
Condition(s):HealthyLast Updated:June 2, 2023Completed
Condition(s):Cystic Fibrosis; Pseudomonas AeruginosaLast Updated:December 13, 2012Approved for marketing
Condition(s):Heart FailureLast Updated:June 27, 2018Completed
Condition(s):Adverse Effect of Antithrombotic DrugsLast Updated:September 17, 2014Completed
Condition(s):Acute Myocardial InfarctionLast Updated:October 11, 2016Unknown status
Condition(s):HealthyLast Updated:December 21, 2020Completed
Condition(s):Cystic FibrosisLast Updated:October 27, 2011Completed
Condition(s):Cystic Fibrosis; Pseudomonas Aeruginosa Airway InfectionLast Updated:August 2, 2011Approved for marketing
Condition(s):HealthyLast Updated:November 21, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.